These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 34958505)

  • 21. Soft Tissue Special Issue: Skeletal Muscle Tumors: A Clinicopathological Review.
    Kohashi K; Kinoshita I; Oda Y
    Head Neck Pathol; 2020 Mar; 14(1):12-20. PubMed ID: 31950473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The expanding morphological and genetic spectrum of MYOD1-mutant spindle cell/sclerosing rhabdomyosarcomas: a clinicopathological and molecular comparison of mutated and non-mutated cases.
    Tsai JW; ChangChien YC; Lee JC; Kao YC; Li WS; Liang CW; Liao IC; Chang YM; Wang JC; Tsao CF; Yu SC; Huang HY
    Histopathology; 2019 May; 74(6):933-943. PubMed ID: 30604891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correspondence re: Parham DM. Pathologic classification of rhabdomyosarcomas and correlations with molecular studies. Mod Pathol 2001;14:506-14.
    Parham DM
    Mod Pathol; 2001 Oct; 14(10):1068. PubMed ID: 11598179
    [No Abstract]   [Full Text] [Related]  

  • 24. Recurrent MYOD1 mutations in pediatric and adult sclerosing and spindle cell rhabdomyosarcomas: evidence for a common pathogenesis.
    Agaram NP; Chen CL; Zhang L; LaQuaglia MP; Wexler L; Antonescu CR
    Genes Chromosomes Cancer; 2014 Sep; 53(9):779-87. PubMed ID: 24824843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytomorphology of spindle cell/sclerosing rhabdomyosarcoma, including MYOD1 (LI22R) mutation result.
    Rekhi B; Dodd L; Dharavath B; Dutt A
    Diagn Cytopathol; 2022 Dec; 50(12):E367-E372. PubMed ID: 35929754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicopathologic features of 300 rhabdomyosarcomas with emphasis upon differential expression of skeletal muscle specific markers in the various subtypes: A single institutional experience.
    Rekhi B; Gupta C; Chinnaswamy G; Qureshi S; Vora T; Khanna N; Laskar S
    Ann Diagn Pathol; 2018 Oct; 36():50-60. PubMed ID: 30098515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methylation alterations of the MyoD1 upstream region are predictive of subclassification of human rhabdomyosarcomas.
    Chen B; Dias P; Jenkins JJ; Savell VH; Parham DM
    Am J Pathol; 1998 Apr; 152(4):1071-9. PubMed ID: 9546368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adult sclerosing rhabdomyosarcoma: cytogenetic link with embryonal rhabdomyosarcoma.
    Croes R; Debiec-Rychter M; Cokelaere K; De Vos R; Hagemeijer A; Sciot R
    Virchows Arch; 2005 Jan; 446(1):64-7. PubMed ID: 15660283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of fusion gene status versus histology on risk-stratification for rhabdomyosarcoma: Retrospective analyses of patients on UK trials.
    Selfe J; Olmos D; Al-Saadi R; Thway K; Chisholm J; Kelsey A; Shipley J
    Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 28035744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rhabdomyosarcoma with epithelioid morphology: A challenging cytologic diagnosis in a pleural effusion.
    Rodgers S; Datta L; Perry KD; Stone CH
    Diagn Cytopathol; 2021 Sep; 49(9):E356-E359. PubMed ID: 34004052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of target genes of PAX3-FOXO1 in alveolar rhabdomyosarcoma.
    Ahn EH; Mercado GE; Laé M; Ladanyi M
    Oncol Rep; 2013 Aug; 30(2):968-78. PubMed ID: 23733015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rhabdomyosarcomas in adults and children: an update.
    Parham DM; Ellison DA
    Arch Pathol Lab Med; 2006 Oct; 130(10):1454-65. PubMed ID: 17090187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pleomorphic rhabdomyosarcoma in children: four cases in the pediatric age group.
    Furlong MA; Fanburg-Smith JC
    Ann Diagn Pathol; 2001 Aug; 5(4):199-206. PubMed ID: 11510002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intergroup Rhabdomyosarcoma Study: update for pathologists.
    Qualman SJ; Coffin CM; Newton WA; Hojo H; Triche TJ; Parham DM; Crist WM
    Pediatr Dev Pathol; 1998; 1(6):550-61. PubMed ID: 9724344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are myogenin and myoD1 expression specific for rhabdomyosarcoma? A study of 150 cases, with emphasis on spindle cell mimics.
    Cessna MH; Zhou H; Perkins SL; Tripp SR; Layfield L; Daines C; Coffin CM
    Am J Surg Pathol; 2001 Sep; 25(9):1150-7. PubMed ID: 11688574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sclerosing rhabdomyosarcomas in children and adolescents: a clinicopathologic review of 13 cases from the Intergroup Rhabdomyosarcoma Study Group and Children's Oncology Group.
    Chiles MC; Parham DM; Qualman SJ; Teot LA; Bridge JA; Ullrich F; Barr FG; Meyer WH;
    Pediatr Dev Pathol; 2005; 8(1):141. PubMed ID: 15803220
    [No Abstract]   [Full Text] [Related]  

  • 37. Classification of rhabdomyosarcoma.
    Newton WA
    Curr Top Pathol; 1995; 89():241-59. PubMed ID: 7882712
    [No Abstract]   [Full Text] [Related]  

  • 38. [Alveolar rhabdomyosarcoma: Two fusion-negative cases lacking PAX3-FOXO1 and PAX7-FOXO1].
    Mestre-Alagarda C; Gómez-Mateo MC; Berenguer-Romero MD; Syonghyun NC; Nieto G; Navarro-Fos S
    Rev Esp Patol; 2022; 55(1):57-62. PubMed ID: 34980443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histopathological, immunohistochemical and molecular cytogenetic analysis of 21 spindle cell/sclerosing rhabdomyosarcomas.
    Rekhi B; Singhvi T
    APMIS; 2014 Nov; 122(11):1144-52. PubMed ID: 24730567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rhabdomyosarcoma Arising in Inflammatory Rhabdomyoblastic Tumor: A Genetically Distinctive Subtype of Rhabdomyosarcoma.
    Dehner CA; Geiersbach K; Rowsey R; Murugan P; Broski SM; Meis JM; Rosenberg AE; Folpe AL
    Mod Pathol; 2023 Jun; 36(6):100131. PubMed ID: 36966552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.